
Cosmos Health (COSM) announced two shareholder-focused actions: the Company intends to resume open-market repurchases under its $5M share repurchase program, and its executive officers and members of its Board of
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| COSM | Cosmos Holdings | 2.81 | -10.74 | -79.27% |
| Name | Price | % Change | |
|---|---|---|---|
| $2.81 | -79.27% |

Cosmos Health (COSM) announced two shareholder-focused actions: the Company intends to resume open-market repurchases under its $5M share repurchase program, and its executive officers and members of its Board of

Cosmos Holdings (COSM) is scheduled to report 3rd quarter earnings on 11/17/2026. Regarding Q3 estimates, Wall Street analysts expect Cosmos Holdings to post earnings of -$0.80 per share. Revenue expectations

19:50 EST Cosmo Health Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on

Cosmos Health (COSM) announced that its U.S. direct-to-consumer subscription business reached $1,832,785 in monthly subscription value as of October 31, equivalent to approximately $22M on an annualized basis. In October,

The latest update is out from Cosmos Holdings ( ($COSM) ). Cosmos Health described shareholder and Board actions concerning its common stock. At the company’s annual meeting, a majority of

Cosmos Health (COSM) announced that its wholly owned pharmaceutical distribution subsidiary, CosmoFarm, is commissioning new automated order-processing and vehicle-loading infrastructure at its distribution center in Peristeri, western Athens, designed to

Cosmos Health (COSM) launched its U.S. subscription model in mid-July 2026 and began scaling it in mid-September as it accelerated investment in its U.S. platform. On October 14, 2026, the

Noble Capital initiated coverage of Cosmos Health (COSM) with an Outperform rating and $1.40 price target U.S. direct-to-consumer sales are gaining momentum, says the analyst, who believes Cosmos is positioned

Cosmos Health (COSM) announced the expansion of its e-commerce and subscription business to Australia, New Zealand and the broader Oceania region. The business is now live across the region, and

Cosmos Health (COSM) announced that, based on its current growth trajectory, it expects U.S. revenue of approximately $15M for the fourth quarter of 2026, with gross profit of approximately $10.5M.
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Initiated | Oct 26, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Apr 21, 2027TBA | $14.14M | ― | ― | 0.02 | -0.21 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.